Professor Duffy is based St Vincent’s University Hospital, Dublin and University College, Dublin. Professor Duffy has a world reputation for his work on cancer biomarkers. He has published in excess of 200 papers on this topic, including articles in high impact journals such as J Natl Cancer Instit, Lancet, BMJ, Cancer Res, Clin Cancer Res, Ann Oncol and Clin Chem. Professor Duffy is a member of a number of International Expert Panels, including the National Academy of Clinical Biochemistry (NACB) (USA) and the European Group on Tumor Markers (EGTM), for establishing guidelines for the clinical use of tumor biomarkers.
One of his main contributions has been the development of a test for identifying patients with breast cancer who may not need chemotherapy. This test, which is known as uPA, is now recommended for clinical use by several expert groups including the American Society of Clinical Oncology (ASCO), the European Society of Medical Oncology (ESMO) and the National Academy of Clinical Biochemistry (NACB) (USA).
In 2012, Professor Duffy was the recipient of the 2012 Abbott Award of the International Society of Oncology and BioMarkers. This award is made annually to investigators, world-wide, who have made an outstanding contribution in the field of basic or clinical oncology. Other awards received by Professor Duffy include the St Luke’s Medal Lecture, the Conway Review Medal Lecture and the Lifetime Achievement Award of the Royal Academy of Medicine in Ireland and the National Committee for Biochemistry Award Medal Lecture of the Royal Irish Academy.